202 related articles for article (PubMed ID: 11770706)
1. Polylactide-poly(ethylene glycol) micellar-like particles as potential drug carriers: production, colloidal properties and biological performance.
Stolnik S; Heald CR; Neal J; Garnett MC; Davis SS; Illum L; Purkis SC; Barlow RJ; Gellert PR
J Drug Target; 2001; 9(5):361-78. PubMed ID: 11770706
[TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of polymer micelles from poly(ethylene glycol)-poly(D,L-lactide) block copolymers as potential drug carrier.
Yasugi K; Nagasaki Y; Kato M; Kataoka K
J Control Release; 1999 Nov; 62(1-2):89-100. PubMed ID: 10518640
[TBL] [Abstract][Full Text] [Related]
3. In vitro degradation behavior of poly(lactide)-poly(ethylene glycol) block copolymer micelles in aqueous solution.
Yang L; El Ghzaoui A; Li S
Int J Pharm; 2010 Nov; 400(1-2):96-103. PubMed ID: 20816736
[TBL] [Abstract][Full Text] [Related]
4. Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density.
Vila A; Gill H; McCallion O; Alonso MJ
J Control Release; 2004 Aug; 98(2):231-44. PubMed ID: 15262415
[TBL] [Abstract][Full Text] [Related]
5. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.
Chen Z; Yu D; Liu C; Yang X; Zhang N; Ma C; Song J; Lu Z
J Drug Target; 2011 Sep; 19(8):657-65. PubMed ID: 21091273
[TBL] [Abstract][Full Text] [Related]
6. Folate-conjugated amphiphilic hyperbranched block copolymers based on Boltorn H40, poly(L-lactide) and poly(ethylene glycol) for tumor-targeted drug delivery.
Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
Biomaterials; 2009 Jun; 30(16):3009-19. PubMed ID: 19250665
[TBL] [Abstract][Full Text] [Related]
7. Surface modification of poly(lactide-co-glycolide) nanospheres by biodegradable poly(lactide)-poly(ethylene glycol) copolymers.
Stolnik S; Dunn SE; Garnett MC; Davies MC; Coombes AG; Taylor DC; Irving MP; Purkiss SC; Tadros TF; Davis SS
Pharm Res; 1994 Dec; 11(12):1800-8. PubMed ID: 7899246
[TBL] [Abstract][Full Text] [Related]
8. Graphene oxide stabilized by PLA-PEG copolymers for the controlled delivery of paclitaxel.
Angelopoulou A; Voulgari E; Diamanti EK; Gournis D; Avgoustakis K
Eur J Pharm Biopharm; 2015 Jun; 93():18-26. PubMed ID: 25817600
[TBL] [Abstract][Full Text] [Related]
9. Micelles formed by self-assembling of polylactide/poly(ethylene glycol) block copolymers in aqueous solutions.
Yang L; Zhao Z; Wei J; El Ghzaoui A; Li S
J Colloid Interface Sci; 2007 Oct; 314(2):470-7. PubMed ID: 17603066
[TBL] [Abstract][Full Text] [Related]
10. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of biodegradable poly(l-lactide)/poly(ethylene glycol) microcapsules containing erythromycin by emulsion solvent evaporation technique.
Park SJ; Kim SH
J Colloid Interface Sci; 2004 Mar; 271(2):336-41. PubMed ID: 14972610
[TBL] [Abstract][Full Text] [Related]
12. Polymeric micelles for the ocular delivery of triamcinolone acetonide: preparation and
Safwat MA; Mansour HF; Hussein AK; Abdelwahab S; Soliman GM
Drug Deliv; 2020 Dec; 27(1):1115-1124. PubMed ID: 32720545
[TBL] [Abstract][Full Text] [Related]
13. Characterization of pegylated copolymeric micelles and in vivo pharmacokinetics and biodistribution studies.
Lin WJ; Chen YC; Lin CC; Chen CF; Chen JW
J Biomed Mater Res B Appl Biomater; 2006 Apr; 77(1):188-94. PubMed ID: 16245284
[TBL] [Abstract][Full Text] [Related]
14. Aggregation behavior of self-assembling polylactide/poly(ethylene glycol) micelles for sustained drug delivery.
Yang L; Qi X; Liu P; El Ghzaoui A; Li S
Int J Pharm; 2010 Jul; 394(1-2):43-9. PubMed ID: 20434530
[TBL] [Abstract][Full Text] [Related]
15. Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles.
Sant S; Poulin S; Hildgen P
J Biomed Mater Res A; 2008 Dec; 87(4):885-95. PubMed ID: 18228249
[TBL] [Abstract][Full Text] [Related]
16. Fusiform micelles from nonlinear poly(ethylene glycol)/polylactide copolymers as biodegradable drug carriers.
Li T; Han R; Wang M; Liu C; Jing X; Huang Y
Macromol Biosci; 2011 Nov; 11(11):1570-8. PubMed ID: 22167874
[TBL] [Abstract][Full Text] [Related]
17. Poly(L-histidine) based copolymers: Effect of the chemically substituted L-histidine on the physio-chemical properties of the micelles and in vivo biodistribution.
Zhang X; Chen D; Ba S; Chang J; Zhou J; Zhao H; Zhu J; Zhao X; Hu H; Qiao M
Colloids Surf B Biointerfaces; 2016 Apr; 140():176-184. PubMed ID: 26764099
[TBL] [Abstract][Full Text] [Related]
18. Preparation of nanoparticles consisted of poly(L-lactide)-poly(ethylene glycol)-poly(L-lactide) and their evaluation in vitro.
Matsumoto J; Nakada Y; Sakurai K; Nakamura T; Takahashi Y
Int J Pharm; 1999 Aug; 185(1):93-101. PubMed ID: 10425369
[TBL] [Abstract][Full Text] [Related]
19. Self-assembled filomicelles prepared from polylactide/poly(ethylene glycol) block copolymers for anticancer drug delivery.
Jelonek K; Li S; Wu X; Kasperczyk J; Marcinkowski A
Int J Pharm; 2015 May; 485(1-2):357-64. PubMed ID: 25796125
[TBL] [Abstract][Full Text] [Related]
20. Micelle-like nanoparticles of PLA-PEG-PLA triblock copolymer as chemotherapeutic carrier.
Venkatraman SS; Jie P; Min F; Freddy BY; Leong-Huat G
Int J Pharm; 2005 Jul; 298(1):219-32. PubMed ID: 15946811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
